We are live on ! Find out more
LVACW

LAVA Medtech Acquisition Corp. Warrants
LVACW

Delisted

LVACW was delisted on the 12th of May, 2023.

Back to rankings

31 hedge funds and large institutions have $1.15M invested in LAVA Medtech Acquisition Corp. Warrants in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

3% less funds holding

Funds holding: 32 → 31 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

61% less capital invested

Capital invested by funds: $2.92M → $1.15M (-$1.77M)

Holders
31
Holders Change
-1
Holders Change %
-3.13%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
2
Closed
4
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
-$3K

Top Buyers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
+$40.2K
2
MF
Magnetar Financial
Illinois
+$4.31K
3
SSA
Schonfeld Strategic Advisors
New York
+$3.51K
4
RCM
Radcliffe Capital Management
Pennsylvania
+$3.13K
5
EFI
EHP Funds Inc
Canada
+$2.88K

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$1.99M
2
FTCM
Fir Tree Capital Management
New York
-$8K
3
CM
Cohanzick Management
New York
-$3K
4
CSS
Cubist Systematic Strategies
Connecticut
-$1.28K
5
BCM
Basso Capital Management
Connecticut
-$207
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$700K +$3.13K +17,804 +34%
SCM
2
Saba Capital Management
New York
$61K – – –
EFI
3
EHP Funds Inc
Canada
$58K +$2.88K +16,400 +4%
PC
4
Periscope Capital
Ontario, Canada
$51K +$40.2K +229,096 +114%
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$47K – – –
FBCM
6
Fort Baker Capital Management
California
$30K – – –
SC
7
Sculptor Capital
New York
$24K – – –
Balyasny Asset Management
8
Balyasny Asset Management
Illinois
$23K – – –
PMAM
9
Picton Mahoney Asset Management
Ontario, Canada
$23K – – –
SCM
10
Shaolin Capital Management
Florida
$20K – – –
LA
11
Linden Advisors
New York
$16K – – –
Goldman Sachs
12
Goldman Sachs
New York
$13K – – –
CSS
13
Cubist Systematic Strategies
Connecticut
$10K -$1.28K -7,322 -6%
TCM
14
Tenor Capital Management
New York
$10K – – –
CH
15
CVI Holdings
Delaware
$9K – – –
BCM
16
Basso Capital Management
Connecticut
$8K -$207 -1,180 -1%
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$8K – – –
AA
18
AQR Arbitrage
Connecticut
$6K – – –
WAM
19
Wolverine Asset Management
Illinois
$6K – – –
SSA
20
Schonfeld Strategic Advisors
New York
$6K +$3.51K +20,000 +80%
AGM
21
Alpine Global Management
New York
$5K – – –
Walleye Capital
22
Walleye Capital
New York
$3K – – –
MF
23
Magnetar Financial
Illinois
$3K +$4.31K +24,549 New
SAMU
24
SONA Asset Management (US)
New York
$2K – – –
Walleye Trading
25
Walleye Trading
New York
$2K – – –
1
2

LVACW Hedge Fund Activity: Q3 2022 in Review

31 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Warrants (LVACW) for Q3 2022, worth a combined $1.15M — down 61% from $2.92M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of LVACW and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.

The largest buyer was Periscope Capital, adding an estimated $40.2K. The largest seller was Mangrove Partners, exiting entirely with an estimated $1.99M sold.

  • 31 institutional investors held LAVA Medtech Acquisition Corp. Warrants (LVACW) as of Q3 2022, down from 32 in Q2 2022.
  • Funds reported $1.15M of LAVA Medtech Acquisition Corp. Warrants stock for Q3 2022, down 61% quarter-over-quarter.
  • 3 funds opened new LAVA Medtech Acquisition Corp. Warrants positions in Q3 2022 and 4 closed out, a net change of -1 holder.
  • The largest LAVA Medtech Acquisition Corp. Warrants buyer in Q3 2022 was Periscope Capital, an estimated $40.2K added.
  • The largest LAVA Medtech Acquisition Corp. Warrants seller in Q3 2022 was Mangrove Partners, an estimated $1.99M sold.

Based on aggregated 13F filings for Q3 2022.